XML 27 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash, Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2018
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Marketable Securities Cash, Cash Equivalents and Marketable Securities 
The following table summarizes the amortized cost and fair value of the Company’s cash, cash equivalents and marketable securities as of December 31, 2018 (in thousands):

Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value 
Current assets: 
Cash and cash equivalents: 
Cash $5,222 $— $— $5,222 
Money market funds 63,232 — — 63,232 
Total cash and cash equivalents $68,454 $— $— $68,454 
Marketable securities: 
Commercial paper $152,940 $— $— $152,940 
Corporate debt securities 60,622 58 (75)60,605 
Certificates of deposit 128,647 — — 128,647 
U.S. Treasuries 103,521 31 (11)103,541 
Total marketable securities $445,730 $89 $(86)$445,733 
Total cash, cash equivalents and marketable securities $514,184 $89 $(86)$514,187 
The following table summarizes the amortized cost and fair value of marketable securities based on stated effective maturities as of December 31, 2018 (in thousands):
Amortized Cost Fair Value 
Due within one year $408,479 $408,471 
Due between one and two years 37,251 37,262 
Total $445,730 $445,733 
As of December 31, 2017, cash and cash equivalents included $289.8 million of money market fund investments having a carrying value equaled to their fair value. The Company did not hold any marketable securities at December 31, 2017.
There have been no significant realized gains or losses on available-for-sale securities for the periods presented. Available-for-sale debt securities that were in a continuous loss position but were not deemed to be other than temporarily impaired were immaterial at December 31, 2018.
See Note 5 for further information regarding the fair value of the Company’s financial instruments.